DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Bayliss J, Yuen L, Rosenberg G. , et al.
Deep sequencing shows that HBV basal core promoter and precore variants reduce the likelihood of HBsAg loss following tenofovir disoproxil fumarate therapy in HBeAg-positive chronic hepatitis B.
Gut 2017;
66 (11) 2013-2023
We do not assume any responsibility for the contents of the web pages of other providers.